Monitoring acute distress in transgender youth initiating gender-affirming care is important given their increased risk for significant mental health symptoms. The current study examined changes in anxiety, depression, and suicidality from initial appointment to first follow-up in 80 youth, ages 11–18. Average time between visits was ∼4 months but varied across participants. Results revealed no change in acute distress from intake to follow-up. Neither distance from medical center nor initiation of hormone therapy was associated with symptom changes. While research shows decreased distress with initiation of hormones, study findings suggest changes may actually take longer to occur.
Get full access to this article
View all access options for this article.
References
1.
MoyerD, ConnellyK, HolleyA. Using the PHQ-9 and GAD-7 to screen for acute distress in transgender youth: findings from a pediatric endocrinology clinic. J Pediatr Endocrinol Metab. 2016; 32:71–74.
2.
ConnollyM, ZervosM, BaroneC, et al.The mental health of transgender youth: advances in understanding. J Adolesc Health. 2016; 59:489–495.
3.
ColemanE, BocktingW, BotzerM, et al.Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012; 13:165–232.
4.
De VriesA, McGuireJ, SteensmaT, et al.Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014; 134:696–704.
5.
HorvathK, IantaffiA, Swinburne-RomineR, BocktingW. A comparison of mental health, substance use, and sexual risk behaviors between rural and non-rural transgender persons. J Homosex. 2014; 61:1117–1130.
6.
SanchezF, SanchezJ, DanoffA. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009; 99:713–719.
7.
RiderG, McMorrisB, GowerA, et al.Health and care utilization of transgender and gender nonconforming youth: a population-based study. Pediatrics. 2018; 141:e20171683.
8.
SaferJ, ColemanE, FeldmanJ, et al.Barriers to health care for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016; 23:168–171.
9.
Human Rights Campaign. Interactive map: clinical care programs for gender-expansive children and adolescents. www.hrc.org/resources/interactive-map-clinical-care-programs-for-gender-nonconforming-childr, Accessed May2019.
10.
RichardsonL, McCauleyE, GrossmanD, et al.Evaluation of the Patient Health Questionnaire (PHQ-9) for detecting major depression among adolescents. Pediatrics. 2010; 126:1117–1123.
11.
LöweB, DeckerO, MüllerS, et al.Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008; 46:266–274.
12.
ColizziM, CostaR, TodarelloO. Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology. 2014; 39:65–73.
13.
Gorin-LazardA, BaumstarckK, BoyerL, et al.Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals. J Nerv Ment Dis. 2013; 201:996–1000.
14.
ManieriC, CastellanoE, CrespiC, et al.Medical treatment of subjects with gender identity disorder: the experience in an Italian public health center. Int J Transgend. 2014; 15:53–65.
15.
NguyenH, ChavezA, LipnerE, et al.Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition. Curr Psychiatry Rep. 2018; 20:110.
16.
TuckerR, TestaR, SimpsonT, et al.Hormone therapy, gender affirmation surgery, and their association with recent suicidal ideation and depression symptoms in transgender veterans. Psychol Med. 2018; 48:2329–2336.
17.
HembreeWC, Cohen-KettenisPT, GoorenL, et al.Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017; 102:3869–3903.
